Innovation Showcase

Innovation Showcase Friday lunchtime



Pluripotent Stem cells research has generated tremendous excitement, and holds promise for the treatment of many uncured diseases. Early stage clinical trials using differentiated induced pluripotent stem cells (iPS) show great potential in cell-based therapeutics. Bridging the gap between research models and clinical applications is the utmost goal to ensure clinically relevant stem cell products. The first part of this innovation showcase will present a research work on SNF5 , which is one of the core subunits of the SWI/SNF chromatin-remodeling complex. Mutations in this protein might have significant effects on the epigenetic state of human embryonic stem cells and on their phenotype and precise levels of SNF5 are required in order to preserve the pluripotent state of the cells. The second part will focus on the manufacturing of clinical grade human iPS under cGMP conditions as a critical part of the translation from research to clinical therapeutics. The innovation showcase will address the challenges of the generation, expansion and storage of iPS cells, including tissue biopsies, xeno-free culture procedures and raw materials, testing and cryopreservation.

Innovation Showcase: Biological Industries

6/22/2018
11:30 - 12:30

Presented by: Biological Industries 

Presentations:

Micha Drukker

Helmholtz Center Munich, Berlin, Germany

Presentation(s):

Send Email for Micha Drukker

Achia Urbach

Bar Ilan University, Yerushalayim, Israel

Presentation(s):

Send Email for Achia Urbach

David Fiorentini

Biological Industries, Hefa, Israel

Presentation(s):

Send Email for David Fiorentini


Assets

Innovation Showcase: THE PROMISE OF INDUCED PLURIPOTENT STEM CELLS: BASIC RESEARCH AND CLINICAL GRADE MANUFACTURING - Biological Industries



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Innovation Showcase: THE PROMISE OF INDUCED PLURIPOTENT STEM CELLS: BASIC RESEARCH AND CLINICAL GRADE MANUFACTURING - Biological Industries